If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

A recent study published in the BMC Pulmonary Medicine unveiled a strong link between the C-reactive protein to albumin ratio ...

Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The air we breathe. Time to act, innovate, and invest in solutions that will make every Indian breathe easy, live fully, and ...

It has been found in a recent study published in Heliyon that individuals who are genetically predisposed to having ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.